SVB Leerink Reiterates Underperform on Incyte, Maintains $63 Price Target

SVB Leerink analyst Andrew Berens reiterates Incyte (NASDAQ:INCY) with a Underperform and maintains $63 price target.

byBenzinga Newsdesk

February 8, 2023

1 minute read

SVB Leerink analyst Andrew Berens reiterates Incyte (NASDAQ:INCY) with a Underperform and maintains $63 price target.

Kraken To Give Out $10M In Bitcoin To Clients Impacted By Ukraine Crisis

By Samyuktha Sriram

Today, 11:02 AM

Major U.S.-based crypto exchange Kraken plans to distribute $10 million worth of Bitcoin (CRYPTO: BTC) to Ukraine-based clients impacted by the Russian invasion.

BTC

News

MySize Amended 13D Filing From Activist Investing/David Lazar Shows Unchanged 9.99% Stake, Includes Amendment For Item 4 In Filing Related To Submission By Firm Custodian Ventures On Jun. 1 Of Books, Records Request

By Benzinga Newsdesk

Today, 11:02 AM

Item 4 is hereby amended to add the following: On June 1, 2021, Custodian Ventures submitted a books and records request (the “Books and Records Request”) pursuant to Section 220 of the Delaware General

MYSZ

FDA Approves Eli Lilly’s Jardiance For Heart Failure

By Vandana Singh

Today, 11:02 AM

The FDA approves Eli Lilly And Co (NYSE:LLY) – Boehringer Ingelheim’s Jardiance (empagliflozin) 10 mg for heart failure. The approval comes to reduce…

LLY

News
Tech

Alibaba Confirms It’s Developing In-House Advanced Chips To Boost Cloud Computing Business

By Rachit Vats

Today, 11:02 AM

Chinese e-commerce giant Alibaba Group Holding (NYSE: BABA) on Tuesday confirmed plans to develop an in-house processor that would be used to power its

AMZN

SVB Leerink Reiterates Underperform on Incyte, Maintains $63 Price Target

Related Posts

Kraken To Give Out $10M In Bitcoin To Clients Impacted By Ukraine Crisis

MySize Amended 13D Filing From Activist Investing/David Lazar Shows Unchanged 9.99% Stake, Includes Amendment For Item 4 In Filing Related To Submission By Firm Custodian Ventures On Jun. 1 Of Books, Records Request

FDA Approves Eli Lilly’s Jardiance For Heart Failure

Alibaba Confirms It’s Developing In-House Advanced Chips To Boost Cloud Computing Business